Antineoplastic Combined Chemotherapy ProtocolsChemotherapy, AdjuvantAntineoplastic AgentsCombined Modality TherapyCisplatinDoxorubicinCyclophosphamideTreatment OutcomeNeoadjuvant TherapyEtoposideDisease-Free SurvivalBreast NeoplasmsNeoplasm StagingSurvival AnalysisMutagensPrognosisLung NeoplasmsSurvival RateDrug Administration ScheduleDNA DamageMethotrexateCarboplatinPaclitaxelInduction ChemotherapyVinblastineMutagenicity TestsNeoplasm Recurrence, LocalTaxoidsNeoplasmsDrug Resistance, NeoplasmTime FactorsBleomycinIfosfamideDeoxycytidineOrganoplatinum CompoundsAntimetabolites, AntineoplasticAntineoplastic Agents, AlkylatingCytarabineAnthracyclinesChemotherapy, Cancer, Regional PerfusionSalvage TherapyFollow-Up StudiesCarcinoma, Non-Small-Cell LungDose-Response Relationship, DrugOvarian NeoplasmsAntineoplastic Agents, PhytogenicNeoplasm MetastasisComet AssayTesticular NeoplasmsAdenocarcinomaVomitingAntibiotics, AntineoplasticTransplantation, AutologousNeutropeniaNauseaLymphoma, Non-HodgkinMitomycinRadiotherapy, AdjuvantCell Line, TumorHodgkin DiseaseColorectal NeoplasmsCamptothecinRadiotherapyPhotic StimulationApoptosisDacarbazineProspective StudiesClinical Trials as TopicNeoplasms, Germ Cell and EmbryonalCarmustineGranulocyte Colony-Stimulating FactorLomustineOsteosarcomaKaplan-Meier EstimateBrain NeoplasmsPlatinum CompoundsTumor Suppressor Protein p53Liver NeoplasmsBone NeoplasmsInfusions, Intra-ArterialLeukopeniaTumor Markers, BiologicalMelphalanAntiemeticsThiotepaInfusions, IntravenousHematopoietic Stem Cell TransplantationDrug TherapyPeritoneal NeoplasmsMitoxantroneRecurrenceLymphatic MetastasisStomach NeoplasmsTegafurPalliative CareAntibodies, Monoclonal, HumanizedGerminomaRadiotherapy DosageCarcinomaCarcinoma, Squamous Cell